Jae E. Park
Busan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
HM-chromanone attenuates obesity and adipose tissue inflammation by downregulating SREBP-1c and NF-κb pathway in high-fat diet-fed mice.
Journal: Archives of physiology and biochemistry
Published: October 03, 2024
Ferulic acid improves palmitate-induced insulin resistance by regulating IRS-1/Akt and AMPK pathways in L6 skeletal muscle cells.
Journal: Toxicology research
Published: July 03, 2024
HM-Chromanone Alleviates Hyperglycemia by Protecting Pancreatic Islet Cells in Streptozotocin-Induced Diabetic Mice.
Journal: Journal of medicinal food
Published: April 21, 2023
HM-chromanone alleviates hyperglycemia and inflammation in mice with endotoxin-induced insulin resistance.
Journal: Toxicology research
Published: February 27, 2023
HM-chromanone from Portulaca oleracea L. inhibits protein tyrosine phosphatase 1B and mitigates glucose production in insulin-resistant HepG2 cells.
Journal: Fitoterapia
Published: January 19, 2023
Scopoletin protects INS-1 pancreatic β cells from glucotoxicity by reducing oxidative stress and apoptosis.
Journal: Toxicology in vitro : an international journal published in association with BIBRA
Published: January 18, 2023
HM-chromanone isolated from Portulaca oleracea L. alleviates insulin resistance and inhibits gluconeogenesis by regulating palmitate-induced activation of ROS/JNK in HepG2 cells.
Journal: Toxicology research
Published: January 12, 2023
HM-chromanone reverses the blockade of insulin signaling induced by high glucose levels in human HepG2 cells.
Journal: European journal of pharmacology
Published: June 10, 2022
HM-chromanone suppresses hepatic glucose production via activation of AMP-activated protein kinase in HepG2 cell.
Journal: European journal of pharmacology
Published: April 18, 2022
A bioactive component of Portulaca Oleracea L., HM-chromanone, improves palmitate-induced insulin resistance by inhibiting mTOR/S6K1 through activation of the AMPK pathway in L6 skeletal muscle cells.
Journal: Toxicology research
Published: April 07, 2022
HM-Chromanone Ameliorates Hyperglycemia and Dyslipidemia in Type 2 Diabetic Mice.
Journal: Nutrients
Published: April 01, 2022
Last Updated: 09/26/2026